PARP Inhibitor Veliparib and HDAC Inhibitor SAHA Synergistically Co-Target the UHRF1/BRCA1 DNA Damage Repair Complex in Prostate Cancer Cells
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-018-0810-7
Full Text
Open PDFAbstract
Available in full text
Date
July 16, 2018
Authors
Publisher
Springer Science and Business Media LLC